•  
  •  
 

Date of this Version

9-25-2019

Document Type

Book Chapters

Summary

  • The process of developing a new therapeutic is long, expensive, and risky.

  • Current small animal models are often poor representations of human disease, contributing to the high rate of failure in human trials.

  • Outbred dogs can be excellent models for researching human disease.

  • Clinical trials in dogs are inexpensive and efficient compared with human trials.

  • Advaxis, a clinical-stage biotechnology company developing cancer immunotherapies, provides one case study on how trials in dogs can help advance trials in humans.

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS